LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 69

Search options

  1. Article ; Online: A central regulation of PTH secretion and function.

    Ducy, Patricia

    Neuron

    2024  Volume 111, Issue 12, Page(s) 1847–1849

    Abstract: PTH orchestrates calcium homeostasis and doubles as a potent, clinically important regulator of bone mass. Adding to the known peripheral regulation of PTH secretion and function, a study by Zhang et al. ...

    Abstract PTH orchestrates calcium homeostasis and doubles as a potent, clinically important regulator of bone mass. Adding to the known peripheral regulation of PTH secretion and function, a study by Zhang et al.
    MeSH term(s) Parathyroid Hormone/metabolism ; Calcium/metabolism
    Chemical Substances Parathyroid Hormone ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2024-01-08
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 808167-0
    ISSN 1097-4199 ; 0896-6273
    ISSN (online) 1097-4199
    ISSN 0896-6273
    DOI 10.1016/j.neuron.2023.05.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Bone Regulation of Insulin Secretion and Glucose Homeostasis.

    Ducy, Patricia

    Endocrinology

    2020  Volume 161, Issue 10

    Abstract: For centuries our image of the skeleton has been one of an inert structure playing a supporting role for muscles and a protective role for inner organs like the brain. Cell biology and physiology modified this view in the 20st century by defining the ... ...

    Abstract For centuries our image of the skeleton has been one of an inert structure playing a supporting role for muscles and a protective role for inner organs like the brain. Cell biology and physiology modified this view in the 20st century by defining the constant interplay between bone-forming and bone resorbing cells that take place during bone growth and remodeling, therefore demonstrating that bone is as alive as any other tissues in the body. During the past 40 years human and, most important, mouse genetics, have allowed not only the refinement of this notion by identifying the many genes and regulatory networks responsible for the crosstalk existing between bone cells, but have redefined the role of bone by showing that its influence goes way beyond its own physiology. Among its newly identified functions is the regulation of energy metabolism by 2 bone-derived hormones, osteocalcin and lipocalin-2. Their biology and respective roles in this process are the topic of this review.
    MeSH term(s) Animals ; Bone Remodeling/physiology ; Bone Resorption/metabolism ; Bone and Bones/metabolism ; Bone and Bones/physiology ; Glucose/metabolism ; Homeostasis/physiology ; Humans ; Insulin/metabolism ; Insulin Secretion/physiology ; Mice ; Signal Transduction/physiology
    Chemical Substances Insulin ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2020-08-21
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 427856-2
    ISSN 1945-7170 ; 0013-7227
    ISSN (online) 1945-7170
    ISSN 0013-7227
    DOI 10.1210/endocr/bqaa149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism.

    Ducy, P

    Diabetologia

    2011  Volume 54, Issue 6, Page(s) 1291–1297

    Abstract: Bone remodelling, which maintains bone mass constant during adulthood, is an energy-demanding process. This, together with the observation that the adipocyte-derived hormone leptin is a major inhibitor of bone remodelling, led to the hypothesis that bone ...

    Abstract Bone remodelling, which maintains bone mass constant during adulthood, is an energy-demanding process. This, together with the observation that the adipocyte-derived hormone leptin is a major inhibitor of bone remodelling, led to the hypothesis that bone cells regulate energy metabolism through an endocrine mechanism. Studies to test this hypothesis identified osteocalcin, a hormone secreted by osteoblasts, as a positive regulator of insulin secretion, insulin resistance and energy expenditure. Remarkably, insulin signalling in osteoblasts is a positive regulator of osteocalcin production and activation via its ability to indirectly enhance bone resorption by osteoclasts. In contrast, leptin is a potent inhibitor of osteocalcin function through its effect on the sympathetic tone. Hence, osteocalcin is part of a complex signalling network between bone and the organs more classically associated with the regulation of energy homeostasis, such as the pancreas and adipose tissue. This review summarises the molecular and cellular bases of the present knowledge on osteocalcin biology and discusses the potential relevance of osteocalcin to human metabolism and pathology.
    MeSH term(s) Animals ; Bone Remodeling/physiology ; Endocrine System/physiology ; Energy Metabolism/physiology ; Humans ; Insulin Resistance/physiology ; Leptin/physiology ; Mice ; Models, Animal ; Osteocalcin/physiology
    Chemical Substances Leptin ; Osteocalcin (104982-03-8)
    Language English
    Publishing date 2011-04-19
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1694-9
    ISSN 1432-0428 ; 0012-186X
    ISSN (online) 1432-0428
    ISSN 0012-186X
    DOI 10.1007/s00125-011-2155-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: 5-HT and bone biology.

    Ducy, Patricia

    Current opinion in pharmacology

    2011  Volume 11, Issue 1, Page(s) 34–38

    Abstract: Bone formation and bone resorption, the two processes occurring constantly and in a balanced fashion throughout the skeleton, are regulated by signals as various as local and low range growth factors, hormones, and neuronal outputs. Adding to the long ... ...

    Abstract Bone formation and bone resorption, the two processes occurring constantly and in a balanced fashion throughout the skeleton, are regulated by signals as various as local and low range growth factors, hormones, and neuronal outputs. Adding to the long list of molecules involved in these regulations, gut-derived and brain-derived serotonin were recently shown to control one or both of these processes. They do so, however, by targeting different cells, respectively acting as a hormone and as a neuromediator. Moreover, while brain serotonin positively regulates bone mass accrual peripheral serotonin is a potent inhibitor of bone formation. These findings raise the prospect that pharmacologically manipulating serotonin production could therefore become a novel strategy to treat bone loss disorders.
    MeSH term(s) Animals ; Bone Resorption/metabolism ; Bone and Bones/metabolism ; Humans ; Osteogenesis/physiology ; Serotonin/metabolism ; Signal Transduction
    Chemical Substances Serotonin (333DO1RDJY)
    Language English
    Publishing date 2011-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2037057-X
    ISSN 1471-4973 ; 1471-4892
    ISSN (online) 1471-4973
    ISSN 1471-4892
    DOI 10.1016/j.coph.2011.01.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: 5-HT and bone biology

    Ducy, Patricia

    Current opinion in pharmacology. 2011 Feb., v. 11, no. 1

    2011  

    Abstract: Bone formation and bone resorption, the two processes occurring constantly and in a balanced fashion throughout the skeleton, are regulated by signals as various as local and low range growth factors, hormones, and neuronal outputs. Adding to the long ... ...

    Abstract Bone formation and bone resorption, the two processes occurring constantly and in a balanced fashion throughout the skeleton, are regulated by signals as various as local and low range growth factors, hormones, and neuronal outputs. Adding to the long list of molecules involved in these regulations, gut-derived and brain-derived serotonin were recently shown to control one or both of these processes. They do so, however, by targeting different cells, respectively acting as a hormone and as a neuromediator. Moreover, while brain serotonin positively regulates bone mass accrual peripheral serotonin is a potent inhibitor of bone formation. These findings raise the prospect that pharmacologically manipulating serotonin production could therefore become a novel strategy to treat bone loss disorders.
    Keywords bone density ; bone formation ; bone resorption ; brain ; growth factors ; hormones ; serotonin ; skeleton
    Language English
    Dates of publication 2011-02
    Size p. 34-38.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 2037057-X
    ISSN 1471-4973 ; 1471-4892
    ISSN (online) 1471-4973
    ISSN 1471-4892
    DOI 10.1016/j.coph.2011.01.007
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring.

    Correa Pinto Junior, Danilo / Canal Delgado, Isabella / Yang, Haiyang / Clemenceau, Alisson / Corvelo, André / Narzisi, Giuseppe / Musunuri, Rajeeva / Meyer Berger, Julian / Hendricks, Lauren E / Tokumura, Kazuya / Luo, Na / Li, Hongchao / Oury, Franck / Ducy, Patricia / Yadav, Vijay K / Li, Xiang / Karsenty, Gerard

    EMBO reports

    2024  Volume 25, Issue 2, Page(s) 593–615

    Abstract: Many physiological osteocalcin-regulated functions are affected in adult offspring of mothers experiencing unhealthy pregnancy. Furthermore, osteocalcin signaling during gestation influences cognition and adrenal steroidogenesis in adult mice. Together ... ...

    Abstract Many physiological osteocalcin-regulated functions are affected in adult offspring of mothers experiencing unhealthy pregnancy. Furthermore, osteocalcin signaling during gestation influences cognition and adrenal steroidogenesis in adult mice. Together these observations suggest that osteocalcin may broadly function during pregnancy to determine organismal homeostasis in adult mammals. To test this hypothesis, we analyzed in unchallenged wildtype and Osteocalcin-deficient, newborn and adult mice of various genotypes and origin maintained on different genetic backgrounds, the functions of osteocalcin in the pancreas, liver and testes and their molecular underpinnings. This analysis revealed that providing mothers are Osteocalcin-deficient, Osteocalcin haploinsufficiency in embryos hampers insulin secretion, liver gluconeogenesis, glucose homeostasis, testes steroidogenesis in adult offspring; inhibits cell proliferation in developing pancreatic islets and testes; and disrupts distinct programs of gene expression in these organs and in the brain. This study indicates that osteocalcin exerts dominant functions in most organs it influences. Furthermore, through their synergistic regulation of multiple physiological functions, osteocalcin of maternal and embryonic origins contributes to the establishment and maintenance of organismal homeostasis in newborn and adult offspring.
    MeSH term(s) Animals ; Female ; Humans ; Mice ; Pregnancy ; Blood Glucose/analysis ; Blood Glucose/metabolism ; Homeostasis ; Insulin/metabolism ; Insulin Secretion ; Mammals/metabolism ; Osteocalcin/genetics ; Osteocalcin/metabolism ; Prenatal Exposure Delayed Effects/metabolism
    Chemical Substances Blood Glucose ; Insulin ; Osteocalcin (104982-03-8) ; Ceacam2 protein, mouse
    Language English
    Publishing date 2024-01-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 2020896-0
    ISSN 1469-3178 ; 1469-221X
    ISSN (online) 1469-3178
    ISSN 1469-221X
    DOI 10.1038/s44319-023-00031-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: How understanding gut serotonin secretion could potentially lead to new treatments for osteoporosis.

    Ortuño, María José / Ducy, Patricia

    Expert review of endocrinology & metabolism

    2014  Volume 8, Issue 2, Page(s) 93–95

    Language English
    Publishing date 2014-03-29
    Publishing country England
    Document type Journal Article
    ISSN 1744-8417
    ISSN (online) 1744-8417
    DOI 10.1586/eem.12.80
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Melanocortin 4 receptor stimulation prevents antidepressant-associated weight gain in mice caused by long-term fluoxetine exposure.

    Ortuño, María José / Schneeberger, Marc / Ilanges, Anoj / Marchildon, François / Pellegrino, Kyle / Friedman, Jeffrey M / Ducy, Patricia

    The Journal of clinical investigation

    2021  Volume 131, Issue 24

    Abstract: Contrasting with the predicted anorexigenic effect of increasing brain serotonin signaling, long-term use of selective serotonin reuptake inhibitor (SSRI) antidepressants correlates with body weight (BW) gain. This adverse outcome increases the risk of ... ...

    Abstract Contrasting with the predicted anorexigenic effect of increasing brain serotonin signaling, long-term use of selective serotonin reuptake inhibitor (SSRI) antidepressants correlates with body weight (BW) gain. This adverse outcome increases the risk of transitioning to obesity and interferes with treatment compliance. Here, we show that orally administered fluoxetine (Flx), a widely prescribed SSRI, increased BW by enhancing food intake in healthy mice at 2 different time points and through 2 distinct mechanisms. Within hours, Flx decreased the activity of a subset of brainstem serotonergic neurons by triggering autoinhibitory signaling through 5-hydroxytryptamine receptor 1a (Htr1a). Following a longer treatment period, Flx blunted 5-hydroxytryptamine receptor 2c (Htr2c) expression and signaling, decreased the phosphorylation of cAMP response element-binding protein (CREB) and STAT3, and dampened the production of pro-opiomelanocortin (POMC, the precursor of α-melanocyte stimulating hormone [α-MSH]) in hypothalamic neurons, thereby increasing food intake. Accordingly, exogenous stimulation of the melanocortin 4 receptor (Mc4r) by cotreating mice with Flx and lipocalin 2, an anorexigenic hormone signaling through this receptor, normalized feeding and BW. Flx and other SSRIs also inhibited CREB and STAT3 phosphorylation in a human neuronal cell line, suggesting that these noncanonical effects could also occur in individuals treated long term with SSRIs. By defining the molecular basis of long-term SSRI-associated weight gain, we propose a therapeutic strategy to counter this effect.
    MeSH term(s) Animals ; Antidepressive Agents/adverse effects ; Antidepressive Agents/pharmacology ; Cell Line ; Fluoxetine/adverse effects ; Fluoxetine/pharmacology ; Humans ; Mice ; Mice, Knockout ; Pro-Opiomelanocortin/genetics ; Pro-Opiomelanocortin/metabolism ; Receptor, Melanocortin, Type 4/genetics ; Receptor, Melanocortin, Type 4/metabolism ; Receptor, Serotonin, 5-HT1A/genetics ; Receptor, Serotonin, 5-HT1A/metabolism ; Receptor, Serotonin, 5-HT2C/genetics ; Receptor, Serotonin, 5-HT2C/metabolism ; Time Factors ; Weight Gain/drug effects ; Weight Gain/genetics
    Chemical Substances 5-hydroxytryptamine2C receptor, mouse ; Antidepressive Agents ; Htr1a protein, mouse ; MC4R protein, mouse ; Receptor, Melanocortin, Type 4 ; Receptor, Serotonin, 5-HT2C ; Fluoxetine (01K63SUP8D) ; Receptor, Serotonin, 5-HT1A (112692-38-3) ; Pro-Opiomelanocortin (66796-54-1)
    Language English
    Publishing date 2021-10-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI151976
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Molecular signaling.

    Ducy, Patricia

    Annals of the New York Academy of Sciences

    2002  Volume 961, Page(s) 161

    MeSH term(s) Animals ; Cell Differentiation ; Genetic Therapy/methods ; Humans ; Signal Transduction
    Language English
    Publishing date 2002-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 211003-9
    ISSN 1749-6632 ; 0077-8923
    ISSN (online) 1749-6632
    ISSN 0077-8923
    DOI 10.1111/j.1749-6632.2002.tb03073.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Cbfa1: a molecular switch in osteoblast biology.

    Ducy, P

    Developmental dynamics : an official publication of the American Association of Anatomists

    2000  Volume 219, Issue 4, Page(s) 461–471

    Abstract: During the past 4 years, our molecular understanding of osteoblast biology has made rapid progress due to the characterization of the function of one molecule, Cbfa1. This member of the runt/Cbfa family of transcription factors was first identified as ... ...

    Abstract During the past 4 years, our molecular understanding of osteoblast biology has made rapid progress due to the characterization of the function of one molecule, Cbfa1. This member of the runt/Cbfa family of transcription factors was first identified as the nuclear protein binding to an osteoblast-specific cis-acting element activating the expression of Osteocalcin, the most osteoblast-specific gene. Cbfa1 was then shown to regulate the expression of all the major genes expressed by osteoblasts. Consistent with this ability, genetic experiments identified Cbfa1 as a key regulator of osteoblast differentiation in vivo. Indeed, analysis of Cbfa1-deficient mice revealed that osteoblast differentiation is arrested in absence of Cbfa1, demonstrating both that it is required for this process and that no parallel pathway can overcome its absence. The importance of Cbfa1 in controlling osteoblast differentiation was further emphasized by the identification of Cbfa1 haploinsufficiency as the cause of cleidocranial dysplasia in humans and mice, a syndrome characterized by generalized bone defects. Lastly, Cbfa1 was shown to have a role beyond development and differentiation, regulating the rate of bone matrix deposition by differentiated osteoblasts. Thus, Cbfa1 is a critical gene not only for osteoblast differentiation but also for osteoblast function. These aspects, as well as the more recent progresses in understanding Cbfa1 biology, are the focuses of this review.
    MeSH term(s) Animals ; Bone Development ; Cell Differentiation ; Chondrocytes/cytology ; Chondrocytes/physiology ; Cleidocranial Dysplasia/genetics ; Collagen/genetics ; Collagen/metabolism ; Core Binding Factor Alpha 1 Subunit ; Gene Expression Regulation, Developmental ; Mice ; Neoplasm Proteins ; Osteoblasts/cytology ; Osteoblasts/physiology ; Osteocalcin/genetics ; Osteogenesis ; Protein Structure, Tertiary ; Transcription Factors/genetics ; Transcription Factors/metabolism
    Chemical Substances Core Binding Factor Alpha 1 Subunit ; Neoplasm Proteins ; Transcription Factors ; Osteocalcin (104982-03-8) ; Collagen (9007-34-5)
    Language English
    Publishing date 2000-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 1102541-4
    ISSN 1097-0177 ; 1058-8388
    ISSN (online) 1097-0177
    ISSN 1058-8388
    DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top